It's no secret that brand-name drugs in the U.S. are much more expensive than they are abroad. In the spirit of fairness, the ...

Regeneron Pharmaceuticals Inc.'s victory against Amgen Inc. over anticompetitive drug bundling reinforces the necessity for ...

IIFL Capital has given an Add rating on Gland Pharma with a target price of Rs 1,650. According to the brokerage, Gland ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...

Taken together, the reports stand as an indictment of the entire programmatic ecosystem. Critics say the unsuitable ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Investors need to pay close attention to Supernus Pharmaceuticals (SUPN) stock based on the movements in the options market ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

India's pharmaceutical industry, which has emerged as the largest supplier of affordable generic medicines, is poised to grow at 7.8 per cent year-on-year in April 2025 driven by strong demand ...

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.